Desvenlafaxine (DVS) is a serotonin-norepinephrine reuptake inhibitor (SNRI) with a different pharmacokinetic and pharmacodynamic profile to venlafaxine. It was approved in February 2008 by the United States Food and Drug Administration for the treatment of major depressive disorder (MDD) based on a ...
Another name for the antidiuretic hormone is ___. 1. For the following hormones: a. give the stimulus for release (hypo/hypercalcemia), b. Describe the mechanism of action (effect on OB/OC) c. Where the hormone is produced d. Effect on b...